Clinical Trial Update: A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia [Phase 3]

View source ↗

Summary

Phase 3 trial update for open angle glaucoma or ocular hypertension conducted in Scandinavia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED